Texas group uses analytics to cut readmissions

Southeast Texas Medical Associates (SETMA), a primary healthcare group based in Beaumont, Texas, is utilizing IBM business analytics software to review trend data to help identify causes and design interventions to prevent patient readmissions.

Using the IBM software, SETMA has cut the number of patient hospital readmissions by 22 percent in the first six months of its practice-level research, by identifying trends and assessing treatment protocols to develop effective post-hospital treatment care programs, according to IBM, of Armonk, N.Y.

The healthcare group is using the analytics software to identify the treatment interruptions and other things that can cause a patient to return into the hospital after discharge, IBM stated. In addition, the software provides patients access to data related to their own personal health goals, so they can view, track and compare their progress to that of other patients with similar conditions, the company added.


Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.